June 5, 2018
Red-Cell Therapeutics™ products are an innovative new class of medicines which address a wide array of diseases and disorders.
Rubius® is developing a new class of medicines to address a wide array of indications, with leading applications in cancer, enzyme replacement therapy and tolerance induction.
We are building a company dedicated to dramatically improving the lives of patients living with serious diseases.
“Our powerful platform with the potential to impact the lives of many patients combined with amazingly dedicated, collaborative, and talented colleagues makes Rubius an incredibly fulfilling and enjoyable place to work. We are not afraid of challenges and rally behind our common goal of developing breakthrough RCT therapies.”
Lenka Hoffman, PhD
“It is refreshing to work at a company with people that are intensely focused on a common goal and moving in the same direction towards that goal. At Rubius we are all treated equally regardless of title. It is the most non-hierarchical place at which I have ever worked.”
Padg Etta Jordan, MA
“Walking into work every day, I feel an energy that is both contagious and exhilarating. The respect, candor and warmth we receive, along with the passion that we all share, is what I truly love about Rubius.”
Senior Research Associate